Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II/III data support potential of rAAV2-ND4 gene therapy in patients with LHON

May 15, 2020

Researchers identify AMRC-835 for MBL-positive Gram-negative bacterial infections

May 15, 2020

Pharmacodynamic and safety data presented for emixustat

May 15, 2020

SHR-170008 immunotherapy demonstrates antitumor efficacy in vivo

May 15, 2020

Kaleido initiates developmental program of KB-109 in mild to moderate COVID-19

May 15, 2020

Krystal Biotech announces positive interim data from phase I/II study of KB-105

May 15, 2020

FDA approves IND application for SMP-100 as treatment of IBS

May 15, 2020

Abivax receives clearance to initiate phase IIb/III study of ABX-464 COVID-19 patients

May 15, 2020

Advaxis reports positive preliminary data from ongoing phase I/II study of ADXS-503 in NSCLC

May 15, 2020

Novadip reports interim data from phase I/II bone non-union study of NVD-003

May 15, 2020

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...